BC
TMO icon

Burleson & Co’s Thermo Fisher Scientific TMO Stock Holding History

Burleson & Co’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.84M Buy
3,336
+2,884
+638% +$1.53M 0.46% 60
2022
Q3 		$229K Buy
452
+335
+286% +$187K 0.05% 125
2022
Q2 		$64K Hold
117
– – 0.01% 170
2022
Q1 		$69K Sell
117
-424
-78% -$244K 0.01% 181
2021
Q4 		$361K Buy
541
+456
+536% +$285K 0.05% 113
2021
Q3 		$49K Hold
85
– – 0.01% 189
2021
Q2 		$43K Sell
85
-21
-20% -$9.91K 0.01% 201
2021
Q1 		$48K Buy
+106
New +$50.6K 0.01% 183

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Burleson & Co's TMO Position: Q4 2022 in Review

Burleson & Co increased its Thermo Fisher Scientific (TMO) stake by 638% in Q4 2022, buying an estimated $1.53M and bringing the position to 3,336 shares worth $1.84M. The position accounts for 0.46% of the portfolio, ranked #60.

Burleson & Co first reported a position in TMO in Q1 2021 and has held it in 8 quarters since. 2,375 funds tracked by Wall St. Rank hold TMO as of Q4 2022.

  • Burleson & Co held 3,336 shares of Thermo Fisher Scientific worth $1.84M as of Q4 2022.
  • Burleson & Co bought 2,884 Thermo Fisher Scientific shares in Q4 2022, an estimated $1.53M.
  • Thermo Fisher Scientific made up 0.46% of Burleson & Co's portfolio in Q4 2022, its #60 holding.
  • Burleson & Co first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 8 quarters since.
  • 2,375 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.